Longterm outcome of a pediatricinspired regimen used for adults aged 1850 years with newly diagnosed acute lymphoblastic leukemia. We present a 36yearold woman with bcell acute lymphoblastic leukemia treated with the calgb 10403 protocol. Peeling paint dermatosis in a leukemia patient jaad case. Jan 22, 2021 the median age was 24 years for calgb 10403 patients and 17 years for the cog aall0232 aya patients. Treatment was initiated with calgb 10403 protocol which included prednisone 60 mgm2day for days 1 28, vincristine 1.
Calgb 10403 treatment consisted of induction, consolidation, interim maintenance, delayed intensification, and longterm maintenance therapy detailed dosing. The nccn recommends cancer patient participation in clinical trials as the gold standard for treatment. An intergroup phase ii clinical trial for adolescents and young adults with untreated. The largest study to date to report outcomes following treatment with a pediatricinspired protocol, calgb 10403, reported a 5% rate of vte in the 295 aya patients who were enrolled. Use of platelet and erythroid growth factors during. A phase iii trial to evaluate the efficacy of the addition of inotuzumabozogamicin a conjugated anticd22 monoclonal antibody to frontline therapy in young adults ages 1839 years with newly diagnosed precursor bcell all.
Role of allogeneic hct as postremission therapy for. Use of platelet and erythroid growth factors during induction. Unique amplification of bcrabl1 gene fusion in a case of t. In the absence of a randomized study comparing both regimens in the aya population, it is important that practitioners adopt the protocol that matches their institutions comfort level, and that they adhere to the protocol in. To determine whether the addition of inotuzumab ozogamicin significantly improves the eventfree survival efs in patients who achieve an induction response achieved with the pediatricinspired regimen of calgb 10403, with censoring for transplant. A pediatric regimen for older adolescents and young. The hypercvad regimen is an optimal pediatricinspired. Philadelphia chromosomenegative bcell acute lymphoblastic. Apr 04, 2019 from november 2007 through september 2012, 318 ayas age 1739 years with newly diagnosed precursor b or tcell all world health organization diagnostic criteria were enrolled in calgb 10403 from 3 us cooperative groups calgb, eastern cooperative oncology group ecog, swog. The nccn guidelines for acute lymphoblastic leukemia all should be consulted for the management of. Comparison of calgb 10403 alliance and cog aall0232. Superior survival with pediatricstyle chemotherapy compared. Evolving therapy of adult acute lymphoblastic leukemia. Comparison of calgb 10403 alliance and cog aall0232 toxicity results in young adults with acute lymphoblastic leukemia.
Nov 15, 2007 burkitt type leukemia as defined per protocol is not eligible. She was also started on imatinib at a dose of 400 mg by mouth. Oct 26, 2017 treatment was initiated with calgb 10403 protocol which included prednisone 60 mgm2day for days 128, vincristine 1. To evaluate the toxicity and tolerability of the addition of inotuzumab ozogamicin to the pediatricinspired regimen of calgb 10403.
The effect of adopting pediatric protocols in adolescents. The consolidation phase may also allow for a deeper remission originally obtained by the first course of induction therapy. C10403 is an aggressive and complex treatment regimen for adolescents and young adults aya with all. May 20, 2020 finally, although the use of pediatricinspired protocols has increased in recent years, particularly after the emergence of prospective data such as the calgb 10403 study, adult protocols, and in particular hypercvad, remains in widespread use, especially in the community setting. In cog aall0232, although 74% of patients aged mar 23, 2021 treatment protocols for acute lymphoblastic leukemia all are provided below, including general treatment recommendations and commonly used treatment recommendations, as well as information on the following. The 2year survival rate with the calgb regimen was 60% only 6 of 26 patients followed beyond 2 years compared with 31. Calgb 10403 treatment consisted of induction, consolidation, interim maintenance, delayed intensification, and longterm maintenance therapy. Toxicities in calgb 10403 were similar to those observed in cog aall0232. A pediatric regimen for older adolescents and young adults with. Jun 05, 2020 these findings appear similar to the calgb 10, 403 results and support hcvad as an acceptable regimen for aya patients.
Lk1504 outcome of hematopoietic stem cell transplantation using total body irradiationbased. Mar 30, 2021 calgb 10403 was a national, singlearm, phase ii study of the feasibility of treating patients aged 1639 years with phnegative all with the standardrisk arm of the cog aall0232 regimen 12. Leukemia group b calgb studies demonstrated that overall survival of patients was superior in ayas treated on ccg protocols. Aya all, 1639 years old i c im di m dnr vcr pred pegasp itmtx itarac cyclo vcr dex pegasp arac 6mp itmtx mtx vcr pegasp itmtx dox cyclo dex pegasp arac 6tg itmtx dex vcr 6mp mtx itmtx. Although the overall complete response cr rate was 90% in both groups, ayas treated on adult calgb trials had only a 34% eventfree survival efs at 7 years, compared to 63% efs in demographically similar. Pegaspargase and esas are known risk factors for development of venous thrombosis and likely contributed to this complication. Peeling paint dermatosis in a leukemia patient jaad. C10403 induction is given to eliminate the majority of leukemia cells from the blood and bone marrow. Calgb 10403 an intergroup phase ii clinical trial for. The pathology revealed the diagnosis and he was initiated on steroids with staging studies revealing mediastinal.
Hemodynamic effect of ivabradine in young girl with acute. From november 2007 through september 2012, 318 ayas age 1739 years with newly diagnosed precursor b or tcell all world health organization diagnostic criteria were enrolled in calgb 10403 from 3 us cooperative groups calgb, eastern cooperative oncology group ecog, swog. The effect of adopting pediatric protocols in adolescents and. Request pdf a pediatric regimen for older adolescents and young adults with. Central nervous system cns prophylaxis the prognosis for various subtypes of all the role of stem cell transplantation in all treatm. Asparaginase dosing, monitoring, and toxicity management. Calgb 10403 treatment consisted of induction, consolidation.
To determine whether changing chemotherapy ct during preop chemoradiation crt based on response to induction ct by 18ffluorodeoxyglucose pet imaging can lead to improved pathologic complete response pcr in patients pts with resectable esophageal and gastroesophageal junction gej adenocarcinomas. Mar 26, 2019 retrospective studies demonstrated superior aya all outcomes using intensive pediatric treatment protocols as compared to less intensive adult protocols, with differences in event. He was found to have an epidural mass from t4 to t8 thoracic and underwent surgical decompression. Calgb 10403 protocol is composed of induction 4 weeks, remission consolidation, interim maintenance, delayed intensification each 8 weeks and maintenance for 23 years. The bfm protocol called for comparison as an effective standard therapy.
Flow cytometric of lymphoblastic leukemias and acute. A pediatric regimen for older adolescents and young adults. In cog aall0232, although 74% of patients aged protocol index ip aya remission induction calgb 10403 types. Acute lymphoblastic leukemia all part 1 of 11 note. Feb 20, 2016 consolidation chemotherapy with pediatricinspired chemotherapy on calgb 10403 or myeloablative allogeneic hematopoietic cell transplantation m wieduwiltw stock protocol development h. Calgb 10403 and other pediatric regimens are typically more complex than many adult regimens and may be challenging to administer outside of a center with larger volume and a support staff familiar with the largely outpatient administration of these regimens. Interestingly, in a large us trial calgb 10403 using a paediatric regimen in.
To determine whether the addition of inotuzumab ozogamicin significantly improves the eventfree survival efs in patients who achieve an induction response achieved with the pediatricinspired regimen of. Induction chemotherapy calgb 10403 protocol bm biopsy from 032016. Acute lymphoblastic leukemia all treatment protocols. A caveat to this analysis is that only 39% of calgb 10403 patients completed all planned protocol treatment. Thai national protocol outcomes outcome is very dependent on treatment patients compliance. Aya all, 1639 years old i c im di m dnr vcr pred pegasp itmtx itarac cyclo vcr dex pegasp arac 6mp itmtx mtx vcr. The nccn guidelines for acute lymphoblastic leukemia all should be consulted for the management of patients with lymphoblastic lymphoma.
C10403 protocol induction trial for all chemoexperts. Jan 26, 2021 a caveat to this analysis is that only 39% of calgb 10403 patients completed all planned protocol treatment. Esas and tpor represent attractive acceptable options for management of chemotherapyinduced cytopenias in jw patients. Combination chemotherapy in treating young patients with. The mortality rate in calgb 10403 was low 4% and similar to that in the cog aall0232 trial. Management of all in adults national cancer institute. Calgb adult group survival of adolescentsyoung adults aya, ages 1620 years blood112.
Pdf effectiveness of modified hypercvad chemotherapy. Deangelo, md, phd danafarber cancer institute alliance a041501. C10403 protocol consolidation for all chemoexperts. Unique amplification of bcrabl1 gene fusion in a case of. A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia. The c10403 protocol is commonly given with the goal of cure. In calgb 10403, 33% of patients were aged 16 to 21 years, 45% were aged 22 to 30 years, and 22% were aged 31 to 39 years vs 92%, 8%, and 0% of the cog aall0232 aya patients p calgb 10403 for patients calgb 10403.
Protocol index ip aya remission induction calgb 10403 types. The c10403 regimen is similar to treatment regimens given to pediatric patients less than 18 y. What is the calgb 8811 regimen for acute lymphoblastic. Favorableoutcomesforolder adolescentsandyoungadults. Aya, all, calgb, 10403, remission, induction, course 1 cycle 1 repeat 1 time cycle length. Combination chemotherapy in treating young patients with newly.
1319 93 1500 382 865 498 312 1015 466 1507 1466 1244 1071 192 1535 748 692 818 1333 637 1453 545 275 607 1151 592 527 1149